Literature DB >> 10743808

Association between clinical factors, socioeconomic status, and organ damage in recent onset systemic lupus erythematosus.

C Rivest1, R A Lew, P M Welsing, O Sangha, E A Wright, W N Roberts, M H Liang, E W Karlson.   

Abstract

OBJECTIVE: To determine the prevalence and socioeconomic and clinical predictors of early organ damage in a cohort of patients with systemic lupus erythematosus (SLE) of 2-7 years' duration randomly sampled at 5 centers and balanced by socioeconomic status and race.
METHODS: The Systemic Lupus International Collaborating Clinics/American College of Rheumatology (SLICC/ACR) Damage Index was measured in 200 patients who met the ACR criteria for SLE with a mean disease duration of 3.8 years. The SLICC/ACR scores for each organ system and the prevalence of damage within organ systems were assessed. Logistic regression analyses evaluated the simultaneous effects of age at diagnosis, disease duration, disease activity, and sociodemographic factors.
RESULTS: Sixty-one percent of the patients had damage within 7 years of onset (mean 3.8 yrs). Neuropsychiatric (20.5%) and musculoskeletal (18.5%) systems were the most frequently involved, followed by renal (15.5%) and skin (12.5%) systems, all with median SLICC/ACR organ system scores of 1. In multivariate models, African-American race was associated with skin damage but not with damage in other specific organ systems. Socioeconomic status was not associated with organ system damage. Older age at diagnosis correlated with cardiovascular, musculoskeletal, gastrointestinal, ocular, and pulmonary damage. Clinical factors such as longer disease duration correlated with higher renal and cardiovascular damage, and greater disease activity at diagnosis of SLE correlated with greater renal, musculoskeletal, and pulmonary damage.
CONCLUSION: There is evidence of organ system damage in SLE within a mean of 3.8 years after onset. We found little evidence for differences in early organ damage according to race or socioeconomic status. Damage to most organ systems was related to age at diagnosis of SLE and clinical factors such as disease duration.

Entities:  

Mesh:

Year:  2000        PMID: 10743808

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  25 in total

1.  Pediatric lupus--are there differences in presentation, genetics, response to therapy, and damage accrual compared with adult lupus?

Authors:  Rina Mina; Hermine I Brunner
Journal:  Rheum Dis Clin North Am       Date:  2010-02       Impact factor: 2.670

2.  Skin is the most frequently damaged system in recent-onset systemic lupus erythematosus in a tropical region.

Authors:  Maria José Pereira Vilar; Elaine Lira Medeiros Bezerra; Emilia Inoue Sato
Journal:  Clin Rheumatol       Date:  2004-12-14       Impact factor: 2.980

3.  Damage index assessment and quality of life in systemic lupus erythematosus patients (with long-term disease) in Northeastern Brazil.

Authors:  Eutília A M Freire; Inês O Maia; Jamile C A Nepomuceno; Rozana M Ciconelli
Journal:  Clin Rheumatol       Date:  2007-01-10       Impact factor: 2.980

4.  Neurological Manifestations in Systemic Lupus Erythematosus: A Single Centre Study from North East India.

Authors:  Sanjeeb Kakati; Bhupen Barman; Sobur U Ahmed; Masaraf Hussain
Journal:  J Clin Diagn Res       Date:  2017-01-01

5.  [Lupus in Germany: analysis within the German lupus self-help organization (LULA)].

Authors:  R Fischer-Betz; E Wessel; J Richter; B Winkler-Rohlfing; R Willers; M Schneider
Journal:  Z Rheumatol       Date:  2005-03       Impact factor: 1.372

6.  Chronic high-dose glucocorticoid therapy triggers the development of chronic organ damage and worsens disease outcome in systemic lupus erythematosus.

Authors:  Tünde Tarr; Gábor Papp; Nikolett Nagy; Edina Cserép; Margit Zeher
Journal:  Clin Rheumatol       Date:  2016-11-26       Impact factor: 2.980

7.  Possible protective effect of hydroxychloroquine on delaying the occurrence of integument damage in lupus: LXXI, data from a multiethnic cohort.

Authors:  Guillermo J Pons-Estel; Graciela S Alarcón; Luis A González; Jie Zhang; Luis M Vilá; John D Reveille; Gerald McGwin
Journal:  Arthritis Care Res (Hoboken)       Date:  2010-03       Impact factor: 4.794

Review 8.  Diagnostic criteria for systemic lupus erythematosus: has the time come?

Authors:  George K Bertsias; Cristina Pamfil; Antonios Fanouriakis; Dimitrios T Boumpas
Journal:  Nat Rev Rheumatol       Date:  2013-07-09       Impact factor: 20.543

9.  Direct costs of ankylosing spondylitis and its determinants: an analysis among three European countries.

Authors:  A Boonen; D van der Heijde; R Landewé; F Guillemin; M Rutten-van Mölken; M Dougados; H Mielants; K de Vlam; H van der Tempel; S Boesen; A Spoorenberg; H Schouten; Sj van der Linden
Journal:  Ann Rheum Dis       Date:  2003-08       Impact factor: 19.103

Review 10.  Understanding the epidemiology and progression of systemic lupus erythematosus.

Authors:  Guillermo J Pons-Estel; Graciela S Alarcón; Lacie Scofield; Leslie Reinlib; Glinda S Cooper
Journal:  Semin Arthritis Rheum       Date:  2009-01-10       Impact factor: 5.532

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.